Physical interaction of distal regulatory elements in three--dimensional space poses a significant challenge for studies of common disease, because noncoding risk variants may be substantial distances from the genes they regulate. Experimental methods to capture these interactions, such as chromosome conformation capture (CCC), usually cannot assign causal direction of effect between regulatory elements, an important component of disease fine--mapping. Here, we developed a statistical model that uses Mendelian Randomisation within a Bayesian hierarchical model framework, and applied it to a novel ATAC--seq data from 100 individuals mapping over 15,000 putatively causal interactions between distal regions of open chromatin. Strikingly, the majority (>60%) of interactions we detected were over distances of <20Kb, a range where CCC--based methods perform poorly. Because we can infer the direction of causal interactions, the model also significantly improves our ability to fine--map: when we applied it to an eQTL data set we reduced the number of variants in the 90% credible set size by half. We experimentally validate one of our associations using CRISPR engineering of the BLK/FAM167A locus, which is associated with risk for a range of autoimmune diseases and show that the causal variant is likely to be a non--coding insertion within a CTCF binding motif. Our study suggests that many regulatory variants will be challenging to map to their cognate genes using CCC--based techniques, but association genetics of chromatin state can provide a powerful complement to these approaches.
Introduction
Three--dimensional (3D) interactions between regulatory elements are a fundamental process in gene regulation 1 . Understanding the guiding principles that control these interactions is a major research interest in genomics 2, 3 . Long--range regulation also poses a significant challenge for studies of human disease because risk variants may be located many kilobases (Kb) from the genes they regulate, making causal variant identification difficult 4, 5 . Chromosome conformation capture (CCC)--based techniques have enabled the generation of genome--scale maps of 3D contacts in human cells 6--8 . These maps have provided valuable insights into large--scale structure and organisation of chromosomes 9, 10 , and often also provide useful information linking distal disease risk alleles with putatively regulated genes 11, 12 . However, it can be hard to distinguish functional interactions, such as enhancer--promoter looping, detected using CCC--based methods from a background of random collisions 13 , which is particularly pronounced over distances of less than 20Kb 11 .
A complementary approach to mapping genome--wide 3D interactions is to utilise germline genetic variation. Quantitative trait loci (QTLs) mapping of chromatin traits can identify genetic variants that regulate chromatin both locally and distally, sometimes over distances of hundreds of kilobases 14--16 . These distal QTLs are known to be enriched in topologically associating domains 14, 15 (TADs), suggesting regulatory regions mapped by chromatin QTLs do indeed physically interact with each other. For fine--mapping of putatively causal variants identified in human disease studies, this approach has some attractive features. First, unlike CCC--based techniques, our ability to detect interactions between regulatory elements is not influenced by the distance between them. Second, QTLs identified in these studies can be naturally aligned with those from disease studies, using colocalisation 17 . Third, causal interactions between different regulatory elements can be deduced using Mendelian Randomisation (MR) technique 18--22 , where germline genetic variants can be used as an instrument to resolve relationships between different active regions. Here we develop and apply a Bayesian hierarchical model that incorporates techniques from MR to map causal regulatory interactions using a novel ATAC--seq data set from 100 unrelated individuals of British ancestry (Online Methods).
Results

The model
Our approach is based on previous observations that associations between genotype at the same genetic variant and chromatin accessibility often appear spread across multiple independent "peaks" of open chromatin, sometimes over great distances 16 . These signals can arise for multiple reasons (Fig 1A) . One possibility is that two or more variants in tight linkage disequilibrium drive independent associations at different peaks (hereafter, referred to as "linkage"). Alternatively, a single variant might independently drive association signals at multiple peaks (referred to as "pleiotropy"). Finally, a single variant could modulate accessibility at one regulatory element that then alters accessibility elsewhere in the genome, an indication that these elements functionally interact in 3D space (referred to as "causality"). Our Bayesian approach classifies peak pairs within 500Kb of one another into hypotheses of linkage, pleiotropy, causality, a single QTL at either of the modelled peaks and a null hypothesis of no QTLs in either peak (Fig. 1A ).
There are three key features of the model. First, support for the hypothesis of a causal relationship between two peaks is computed using MR. Second, we use a hierarchical model 23 in which prior probabilities depend on a range of genomic annotations at multiple model levels. Third, the model is empirical, such that the prior probabilities are learned as the likelihood is maximised across all peak pairs simultaneously. We model the relationship between genotype and a pair of chromatin accessibility peaks (Fig. 1B) . To compute the pairwise likelihood for a given peak pair j and k, we calculate Bayes Factors (BF j and BF k ) for the association between genotype at a putative causal genetic variant and chromatin accessibility at each member of the pair. For the hypothesis of causality we compute a Mendelian Randomisation Bayes Factors (MR BF j (k) and MR BF k (j) ) for the regression of chromatin accessibility in peak j on peak k (or vice versa) using the two stage least squares method 24 , with genotype at the given genetic variant as the instrumental variable (Fig. 1B) . Using this information, the model can compare support for a causal effect of one peak on another, relative to the alternatives of pleiotropy, or two independent causal variants (linkage). Because the true causal variant is unknown, BFs are calculated for all variants in a cis window extending 500Kb 5' and 3' and marginalised by appropriate prior probabilities to derive the regional BF (RBF) (Fig. 1C) . We use a "variant--level" prior probability of being a causal regulatory variant within cis window, based on variant location relative to and within a peak (Fig. 1D) , and assuming a single causal variant in the window. We also model a "peak--level" prior on the probability of observing a caQTL, which is a function of peak height (Fig. 1E) . This adjusts the support for QTL by the amount of data that supports that peak, an approach that is conceptually similar to independent hypothesis weighting 25 . Finally, we model a "peak--pair--level" prior that adjusts the support for pleiotropy or causality between two peaks, as a function of the distance between them (Fig. 1F ) (see Online Methods for detail). During initial model testing, we found that allowing for distance dependence between peaks provided a substantially better fit to the data than a uniform probability of interaction (Chi--square statistic=59,361 with DF=10; P<10 --12873 ). Our data also strongly supported that causal interactions occurred over shorter ranges than pleiotropic (Fig. 1F) . Following maximisation, the model outputs a posterior probability that a peak pair belongs to one of the interaction categories, including the posterior probabilities of a causal interaction (PPCs). For example, PPC jk denotes the posterior probability that peak j regulates, or is "upstream" of peak k, while PPC kj denotes the converse (j is "downstream" of k). In what follows, we use PPC to refer to the sum of PPC jk and PPC kj .
Mapped causal interactions
Of the 17 million peak pairs we considered genome--wide, 14% showed some evidence of genetic control, either a single QTL, linkage or some form of interaction (Fig.  1G) . Summing over the posterior probabilities, we estimated that 23,036 peak pairs (0.13%) causally interact, of which 15,487 were high confidence, with posterior probability greater than 0.5. Our empirical prior suggested that the probability of any two peaks within 500Kb of each another interacting was 1.4% (Fig. 1F) suggesting that 1.23% or over 220,000 causal interactions remain to be discovered, although this is likely to be an underestimate. Following the initial round of interaction detection, we performed a post--hoc summarisation to identify directed acyclic graphs (DAGs) of causally interacting peaks in our high confidence call set (Online Methods). We identified 3,557 independent DAGs (Fig.  S1A) , of which 1,366 DAGs consist of more than 2 peaks up to 60 peaks as maximum at the MB21D2 locus (Fig. S1B ) that we previously reported 16 . Fig. S1C is an example of DAG with three peaks in which the leftmost peak A regulates the flanking two peak B and C which are in pleiotropic relationship. The majority of causal interactions occur over sub 20Kb distances Next we compared the 23,036 mapped causal interactions with loops inferred from Hi--C, promoter Capture Hi--C (Chi--C) and H3K27ac HiChIP applied to GM12878 10--12 ( Fig. 2A) . More than 70% of the causal interactions we detected were between peaks located within the same topologically associating domains (TADs) called from Hi--C, an approximately 5--fold enrichment over genomic background ( Figure 2B , C). Our interactions were also enriched for loops inferred from H3K27ac HiChIP and CHi--C data (7.7 and 1.4--fold, respectively), although the absolute numbers of overlaps were small (152 and 324, Fig 2C, B) . This low overlap reflects the much shorter distances over which our interactions occurred ( Fig. 2D ): 63% were less than 20Kb distant from one another, compared with 7% of CHi--C interactions ( Fig. 2D; Fig. S2A ). Interaction distances were slightly longer when one member overlapped an annotated promoter ( Fig. S2B ; 49--54% < 20Kb). Thus, our approach revealed many functional three dimensional interactions are likely to be below the resolution of conventional CCC--based techniques. Our results also highlighted interactions that would be missed by promoter capture--based techniques. For example, there were 2,208 causal interactions between enhancers linked to the same baited promoter (Fig.  2B,  C) , and a further 561 causal interactions between two peaks located within the same CHi--C bait region. One example of a candidate short--range causal interaction at the promoter region of the MAP1B gene is shown in Fig.  2E . Here, a strong caQTL harbouring a putative causal SNP (rs1217817) is located immediately distal to the promoter flanking region that is causally interacting with the promoter peak with high confidence (PPC=1.0). Although this region overlaps a contact domain called from CHi--C, this interaction does not have strong statistical support (CHICAGO score 1.87) due to the short distance (<13Kb).
Enhancer--enhancer and promoter--enhancer interactions are common
We next examined the functional classes to which the members of causally interacting regulatory elements belonged, using the ENCODE genome segmentation annotations for LCLs 26, 27 (Online Methods). The most frequent class of interactions (5,061 peak pairs, 22% of all interactions) were strong enhancers that appeared to regulate other element types, including other strong enhancers (1,531 peak pairs, 6.6%), a 2.5--fold enrichment (Fig. 3A, B) . When we focussed only on variants that also altered gene expression, using 4,670 interacting peak pairs that jointly colocalised with an eQTL from the GEUVADIS data set (Online Methods), we found these were enriched (2.4--fold, P=6.4×10 --19 ) for strong enhancer to active promoter interactions (Fig  3C,  D) . However, expression--associated variants were also enriched for interactions from active promoters to strong enhancers (2.2--fold) or between pairs of strong enhancers (2.2--fold enrichment) (Fig. 3D) . One hypothesis is that many of these are mediated by transcriptionally induced changes in chromatin accessibility over the gene body, which create apparent interactions between a single upstream functional element and chromatin peaks throughout the transcribed region. A striking example of this potential phenomenon is found at the MB21D2 locus (Fig. S1C ). This hypothesis is consistent with the observation that chromatin accessibility over the gene body is highly correlated with gene expression level ( 
Genetically--driven changes in the reference epigenome
We found a surprisingly large number of interactions (4,134 peak pairs) originating from within repressed regions (Fig. 3A) . Preliminary analysis suggested that these might arise due to genotype effects on the reference epigenome annotation derived from a single individual (GM12878). To test this, we stratified all upstream peaks in causally interacting pairs based on whether their lead caQTL genotype in GM12878 was increasing homozygote, decreasing homozygote or heterozygote (Online Methods). Upstream repressed regions were highly enriched (3.1--fold) for decreasing homozygotes compared with increasing homozygotes (Fig. 3E) , suggesting that in these cases a strong caQTL almost completely removes a region of open chromatin in GM12878, an example of which is shown in Fig. 3F .
Causal interactions improve fine--mapping
Next we examined whether the information on causal direction of variant effects could be used to improve fine--mapping accuracy, using gene expression as a model quantitative trait. For each peak within a 1Mb cis--window around a gene TSS, we first computed the probability of master regulator (PMR) for each peak (see Online Methods). We then used a hierarchical model 23 to compute the posterior probabilities of association (PPA) for eQTL variants with PMR and the following four other annotations: (1) inside or outside an ATAC peak, (2) eQTL variant location, relative to an ATAC peak coverage, (3) promoter CHi--C contacts, (4) HiChIP loops from promoter regions (see Online Methods for details). Genome--wide, the best performing annotation was the combination of PMR with ATAC peak status and variant location, which reduced the 90% credible set of eQTL variants by 65%, from 17 to 6 variants on average, compared with 11 variants for CHi--C, 10 for ATAC peaks and 8 for Chi--C combined with ATAC peaks (Fig. 4A) . We examined the effect of adding information on the causal direction via the PMR, by comparing to variants annotated using ATAC peak data alone. The PMR annotation significantly reduced the credible set size (P<10 --49 , paired t--test). We then compared our results with data from massively parallel reporter assay (MPRA) performed in LCLs 28 . Here, we selected the lead eQTL variants, ranked by the eQTL PPAs for each annotation and asked how many overlapped a validated expression--modulating variant (an "emVar") from the MPRA (Online Methods). We found the highest overlap (21.6% or 182 emVars) for the combined PMR, ATAC peak and variant location annotations (Fig.  4B) . We show an example of this approach applied to a challenging locus in Fig.  4C , where a strong eQTL for the GPATCH2L gene is associated with more than 100 candidate regulatory variants in almost perfect LD. With no annotation information, the 90% credible set size at this locus is large, at 65 variants. Although different annotations produce varying effects, our model proposes a single SNP, rs74067641, as the likely causal regulator with the highest posterior probability (PPA=0.42). This is because this variant is located within what our model predicts to be a master regulatory peak located furthest upstream in the regulatory cascade (Fig. S4) . CRISPR validation of a putatively causal variant at the BLK locus Finally, we applied our method in an attempt to fine--map a challenging GWAS locus with contradictory evidence for multiple causal variants in previous studies. The BLK/FAM167A locus on 8p21 has a strong eQTL (gEUVADIS P<10
--26 and 10 --46 for BLK and FAM167A genes, respectively) in LCLs (Fig. 5A ) that colocalises well with genome wide significant associations for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) (Fig. S5.1A--B) . Previous attempts to fine--map this locus have been hampered by multiple genetic variants in tight LD (Fig.  S5.1C--D) . Two SNP variants, rs1382568 and rs922483, located near the promoter of BLK gene, have previously been reported as putative causal variants of SLE that alter BLK expression in various B and T cell lines 29 . However, MPRA studies have pinpointed an alternative deletion variant (rs5889371) that might also potentially alter BLK expression in LCLs 28 . Nonetheless, two of the previously reported variants (rs5889371, rs1382568) are located in regions of low chromatin accessibility (Fig. S5E--G) and therefore less likely to causally influence BLK expression. We detected a single base pair insertion variant (rs558245864) located in a strong caQTL peak 14Kb upstream of the BLK promoter that interacted with 15 flanking peaks including several promoter peaks (Fig.  5A) . The insertion variant showed the highest posterior probability (PPA=0.59) of any putatively causal eQTL variant for BLK gene (Fig. 5A ). This variant is located at the middle of a canonical CTCF binding motif, with an extra "G" nucleotide decreasing the predicted CTCF binding affinity to almost to background (Fig. 5B) . The direction of binding affinity change was consistent with the caQTL signal. This variant was also a CTCF ChIP--seq QTL (Fig. 5B) , with 99.7% the probability of colocalisation between CTCF binding and the caQTL for this peak (Online Methods). We used CRISPR/Cas9 genome engineering to generate two different heterozygous deletion lines from a parental line that was homozygous for the high CTCF binding allele (Online Methods). These deletions overlapped the CTCF binding site: the 6bp deletion disrupts the right hand side of the binding site and the 18bp deletion that removes almost the entire motif (Fig. 5B) . ATAC--seq and RNA--seq in the deletion lines revealed a significant down--regulation of chromatin accessibility at the focal peak compared with the parental line (P=0.0005) (Fig. 5C) , and a concomitant down--regulation of BLK expression (P=0.0095) (Fig. 5D) . We also observed decreases in accessibility at some neighbouring peaks (Fig. S5H ) and increase in expression at the nearby FAM167A gene (Fig. S5I) as the eQTL results would have predicted, although it is not significant (P=0.18).
Discussion
We have presented a novel approach to detect interactions between regulatory elements that utilises principles of Mendelian Randomisation technique within a Bayesian hierarchical model. We show that the majority of causal interactions within 500Kb occur over short distances (<20Kb), typically a region of low sensitivity for CCC--based techniques. Many of the interactions we detect are between enhancers, which we assemble into hierarchies of interacting regulatory elements. We demonstrate that our model can be used to identify hierarchies of regulatory elements within a region and prioritise putatively causal variants, validating a single locus using CRISPR/Cas9 editing.
The low frequency of long--range interactions we observed agrees with previous estimates from eQTL studies 23, 30, 31 . One question is why, given that most regulatory interactions detected using CCC--based methods over distances of 100Kb and above (Fig. 2D ), large numbers of genetic variants operating at these distances have not been detected by QTL studies. This partly reflects the fact that QTL studies often test variants in a cis window of less than 1Mb 30--32 . However, even technical reasons seem insufficient as an explanation, given that the number of eQTL associations detected decreases dramatically by approximately 20Kb distant from the gene TSS 23, 31 . One explanation is that there may be an underlying relationship between interaction distance and cellular frequency, such that long--range interactions occur in a relatively small number of cells in the population 30 . An observation supporting this hypothesis is the strong negative correlation between read coverage and distance in Chi--C data (Fig. S6A) . It seems plausible that CCC--based methods could be more sensitive to rare, long--range regulatory interactions while variants residing in these elements have relatively weak effects 31 , requiring large sample sizes to detect when averaged across the entire cell population. If this hypothesis holds, our results highlight the importance of better characterisation of the mode of action of disease associated variants at the single cell level. One of the limitations of our method is that regulatory elements lacking a common genetic variant that perturbs their function will be missed by our method. Additionally, interactions between genotype and regulatory elements further downstream appear to become harder to detect, perhaps due to additional biological noise. One example of this is the systematically lower genetic effect sizes (14 % decreasing) we found at downstream promoters (Fig. S6B, C) .
Our study also revealed the genomic architecture of causal interactions between regulatory elements. In particular, we detected frequent interactions between annotated enhancer elements, many of which we hypothesise are mediated by an intermediate eQTL that alters chromatin accessibility globally across the gene body. Nonetheless, the enrichment of these interactions in gene bodies was modest, and we also found many examples of interactions that were not colocalised with eQTLs, and were located far from annotated genes (an example is shown in Fig.  S6D) . In a small number of cases (18 DAGs) we also found strong evidence (PPC > 0.5 for each enhancer pairs) that these occurred between multiple enhancers upstream of a promoter (i.e., SE→SE→AP). It is possible that some of these represent enhancer "seeding" events, where individual enhancers drive progressive activation of additional nearby elements 33 . The approach we have developed allows for a natural prioritisation of variants in disease--associated loci. Although overlapping of disease associated variants with open chromatin can reduce credible sets, this frequently leaves many loci with tens of variants to characterise by direct experimental follow up. Assignment of the direction of effect between different peaks allowed us to identify smaller sets of plausible candidate variants by identifying "master regulatory" regions. Although here we have focused on ATAC--seq data, we believe our model can be readily extended to other types of chromatin--based assay, in particular ChIP--seq for histone modifications 14, 15 . Some limitations of this approach might include a greater difficulty in assigning causal variants based on their location within a ChIP--seq peak, which will typically be in a nucleosome depleted and therefore low read coverage 14 (Fig. S6B) . However, we anticipate that, applied to existing data sets from primary cells, such as that generated by the BLUEPRINT initiative 34 , that our approach will be a valuable tool in dissecting the molecular architecture of specific GWAS loci.
Online methods
ATAC--seq in LCLs
We collected 76 LCL samples of British ancestry (1000 Genomes Project GBR) that we combined with 24 LCL samples previously sequenced 16 . We also performed an additional ATAC--seq experiment in GM12878 that was not used for QTL mapping, but was used to assess genotypic effects on the reference epigenome. ATAC--seq library preparation was performed as previously described 16 . We performed 75bp paired end sequencing in 4.4 billion sequence fragments on a HiSeq 2500 (Illumina). See Section 2 of Supplementary Note for more details.
Sequencing data preprocessing
All sequence data sets were aligned to human genome assembly GRCh37. FASTQ files of GEUVADIS RNA--seq data 32 (N=372) were downloaded from ArrayExpress (Accession E--GEUV--3), ChIP--seq data for CTCF binding 35 (N=50) were downloaded from the European Nucleotide Archive (Accession ERP002168). Our ATAC--seq data and the CTCF ChIP--seq data were aligned using bwa 0.7.4 36 . RNA--seq data were aligned using Bowtie2 37 and reads mapped to splice junctions using TopHat2 38 , using ENSEMBL human gene assembly 69 as the reference transcriptome. Following alignment, we performed peak calling in the CTCF ChIP--seq and ATAC--seq data by pooling all samples. Fragment counts of ATAC--seq, CTCF ChIP--seq and RNA--seq for each feature (a called peak or an union of exons for each gene) were normalised into FPKMs using length referred to the peak length in kilobases. Batch effects were adjusted by GC contents and principal components. See Section 3.1--3.5 of Supplementary Note for more detail.
SNP genotype data
We downloaded VCF files from the 1000 Genomes Phase III integrated variant set from the project website (http://www.internationalgenome.org/data). For the ATAC--seq, RNA--seq and CTCF ChIP--seq samples that did not overlap with the 1000 Genomes Phase III samples, we extracted genotype data from the 1000 Genomes Phase I data or 1000 Genomes high density SNP chip data (performed on the Illumina Omni platform). We then performed whole genome imputation for the extracted genotype data by using the Beagle software 39 (version: 23--Jul--16). See Section 3.6 in Supplementary Note for details.
Genomic annotations
To compute ATAC--seq peak height, we pooled ATAC--seq data for the 100 samples. The peak height was defined as the highest value of the coverage depth within each peak region. Peak height quantile normalised across all peaks. The relative coverage at each variant location was calculated by the absolute coverage depth divided by the peak height inside the peak. This value was used as the variant location (VL) prior probability for both caQTL mapping and eQTL mapping. Peak distance was calculated based on the midpoint of a peak region. We also used various external genomic annotations for comparison. The Hi--C contact map and Hi--C loops for GM12878 were obtained from Rao et al. (2004) 10 . TAD boundaries were defined as the anchor regions of a Hi--C loop. Capture Hi--C data for GM12878 was obtained from Cairns et al. (2016) 13 and CHiCAGO 13 software was used to extract CHi--C interactions with CHiCAGO score > 1. The H3K27ac HiChIP data for GM12878 was obtained from Mumback et al. (2017) 12 . The JuiceBox output was processed by HiCCUPS 40 with default parameter setting to obtain the HiChIP loops. The integrated genomic segmentation annotation 27 combining Segway 41 and ChromHMM 42 results was downloaded from ENCODE Project 26 website (http:// hgdownload.soe.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeAwgSegmentatio n/). Each ATAC peak was labelled by one of the 7 different segmentation categories at the peak midpoint. See Section 3.7 in Supplementary Note for details.
Pairwise hierarchical model
The pairwise hierarchical model is a product of finite mixture probabilities over all j--k peak pairs in 500Kb ( 1 ≤ < ≤ ; = 277,128 ). The finite mixture model comprises the regional Bayes factor ( !" ! ) to observe chromatin accessibility ! and ! at peak and across 100 samples under the different interaction hypotheses ℎ (Fig. 1A) . The pairwise likelihood is given by
where ! denotes the mixture probability that j--k peak pair is no caQTLs, ! denotes the mixture probability for the alternative hypothesis ℎ and ! is the set of alternative hypotheses, so that
. RBF is obtained from the joint regression model ( ! , ! |ℎ) which comprises two independent regression models that also depend on the hypothesis ℎ. For the causality hypotheses ( !.! for the causal interaction from peak j to k and !.! for peak k to j), we used the two stage least square 24 (2SLS) method to estimate the causal effect between peaks with each genetic variant in the cis window as the instrumental variable (Fig. 1C) . To reduce the computational complexity, we employed a two--stage optimisation of the likelihood. In the first stage we estimated hyperparameters for the variant--level and peak--level prior probabilities. We used the standard hierarchical model 23 to learn these prior probabilities by temporarily assuming peaks are independent. In the second stage, we estimated hyperparameters in the peak--pair--level prior regarding ! . We used the Expectation--Maximisation algorithm to iteratively estimate hyperparameters while updating the following posterior probabilities
in the E--step. Because all model distributions belong to exponential family, we can utilise the penalised iteratively reweighted least square (P--IRLS) method 43 in the M--step, which does not require calculation of the gradient and Hessian of the log likelihood. All subsequent analyses were performed based on the posterior probabilities !" ! without any threshold. Note that the posterior probability of causality (PPC) is denoted by PPC jk and PPC kj (corresponding to !" (!.!) and !" !.! , respectively) in the main text. Mathematical rationale and implementation of the pairwise hierarchical model are fully described in Section 4.1--4.5 of Supplementary Note. The software is available from GitHub (https://github.com/natsuhiko/PHM).
Mapping multi--way interactions
Multi--way interactions were also constructed from PPC jk and PPC kj by finding a DAG among more than 2 peaks. We first used only confident causal interactions with PPC jk >0.5, then found the most likely parent for each peak, and finally solve the cyclic graphs by discarding an interaction with the lowest PPC jk . See Section 4.6 of Supplementary Note for details.
Detection of lead caQTL variant
Within each cis--regulatory window (500Kb on either side of a peak), we calculated a posterior probability of each variant being the causal caQTL and obtained the maximum a posteriori variant as the lead variant. We used the pairwise likelihood to solve the problem that multiple caQTL variants are associated with chromatin accessibility due to strong linkage disequilibrium. The central assumption here is that variants predicted by our model to be upstream in the regulatory cascade are more likely to be causal. See Section 4.7 in Supplementary Note for details. 1B are calculated for all variants in a cis--window and averaged as the regional Bayes factor (RBF) . The schematic shows the two types of BFs across all variants were averaged by the variant level prior probability that the peak j is upstream of k (genetic variant is causal to peak j) to map causal interaction from j to k. (D) The estimated relative caQTL enrichments for genomic annotations used to compute the variant level prior probability in Fig 1C. (E) The estimated prior probability of a peak being a caQTL as a function of the peak height quantile among 277,128 peaks. The B--spline function was applied to capture non--linear relationship. (F) The estimated prior probability that a peak pair is pleiotropic or causal as a function of peak distance. Two different B--spline functions were applied. Independent analysis of CTCF ChIP--seq binding QTL supports the result. CRISPR engineering was performed to generate two different deletions (D1 and D2) from the parental line (HG00142) whose genotype is reference homozygote at the insertion variant. The maximum CTCF binding affinity around the region after extracting the deleted sequences is lower than that of the alternative allele. (C) FPKMs at the focal peak for the two heterozygous deletion lines (D1: green and D2: orange) compared with the parental line with reference homozygote (R/R: navy). All lines were replicated twice. (D) FPKMs of BLK gene expression for the same lines in Fig. 5D .
